Clinical Trials on HER2 Positive Metastatic Breast Cancer in United States
Total 8150 results
-
Legacy Health SystemTerminatedMetastatic Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage I Breast Cancer | Cancer Survivor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage... and other conditionsUnited States
-
Polly A. Niravath, MDRecruitingBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
University of Pittsburgh Medical CenterCompletedBreast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Western Regional Medical CenterTerminatedEstrogen Receptor Positive Breast CancerUnited States
-
University of Alabama at BirminghamNot yet recruitingMetastatic Breast CancerUnited States
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast Cancer | Breast Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingBreast Cancer | Metastatic Breast CancerUnited States
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCTerminated
-
University of Texas Southwestern Medical CenterWithdrawn
-
Baylor Breast Care CenterPfizerTerminatedMetastatic Breast CancerUnited States
-
University of Wisconsin, MadisonSanofiCompleted
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
University of MiamiGenentech, Inc.TerminatedBreast Cancer | Metastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Foundation MedicineCompletedMetastatic Breast CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteEli Lilly and Company; Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Stanford UniversityWithdrawnBreast Cancer | Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
BionovoUnknownMetastatic Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsActive, not recruitingHormone Receptor-positive Breast CancerUnited States
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast CarcinomaUnited States
-
University of WashingtonTerminatedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
Medical College of WisconsinLoyola University ChicagoRecruitingMetastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Foundation MedicineActive, not recruitingMetastatic Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedMetastatic Breast CancerUnited States
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Washington University School of MedicineMerck Sharp & Dohme LLCTerminatedMetastatic Breast CancerUnited States
-
West Virginia UniversityOrtho Biotech, Inc.CompletedMetastatic Breast CancerUnited States
-
Immunovative Therapies, Ltd.WithdrawnMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Hematology Oncology ConsultantsOrtho Biotech, Inc.UnknownMetastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Massachusetts General HospitalMerck Sharp & Dohme LLCActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
University of PennsylvaniaCompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Kathy MillerCompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
C. Kent Osborne, MDMirati Therapeutics Inc.WithdrawnBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
University of GlasgowNHS Greater Glasgow and Clyde; Tenovus ScotlandRecruitingBreast Cancer | HER2-positive Breast Cancer | CardiotoxicityUnited Kingdom
-
Merrimack PharmaceuticalsSanofiCompletedLocally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, | Primary Peritoneal Cancer or Endometrial Cancer | Locally Advanced/Metastatic Her2 Non Overexpressing Breast CancerUnited States
-
Genta IncorporatedUnknownMetastatic Breast Cancer | Locally Advanced Non-resectable Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedMetastatic Breast CancerUnited States